Adding laser-based antimicrobial therapy to deep cleaning and tongue scraping for bad breath in people with type 2 diabetes and severe gum disease
Official title: Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus: A Randomized Clinical Trial
Run by University of Sao Paulo · NCT07463859 · Data updated 2026-11-12
This trial tests whether adding antimicrobial photodynamic therapy to standard deep cleaning and tongue scraping reduces bad breath in people with type 2 diabetes and advanced periodontitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (Bauru, São Paulo) |
| Status | Recruiting |
| Started | April 2, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | March 16, 2026 |
| Trial ID | NCT07463859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with type 2 diabetes (per WHO 2019 criteria), stage 3 or 4 periodontitis, at least 20 remaining teeth, no periodontal treatment in the prior 12 months, and who meet the study's non-smoking and health criteria.
✕Probably not a fit
People who smoke, are alcohol-dependent, are pregnant or lactating, have renal disease, use medications that affect the periodontium, or who do not have advanced periodontitis or have fewer than 20 teeth are not good candidates and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants receive conventional periodontal treatment (scaling and root planing) plus tongue scraping, and some participants also receive antimicrobial photodynamic therapy (aPDT) using methylene blue and a light source. Treatments are given weekly for one month, followed by monthly maintenance visits up to six months. Researchers will compare breath odor measurements and periodontal health outcomes between the groups to see if aPDT provides additional benefit. The trial is conducted at the Bauru School of Dentistry, University of Sao Paulo.
Why it matters
Potential benefit: If successful, adding aPDT could further reduce bad breath and improve gum health for people with diabetes and severe periodontitis.
How similar studies have gone: Previous small trials of aPDT as an adjunct to conventional periodontal therapy have shown promising but mixed results, so the approach has some supportive evidence but is not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with type 2 diabetes mellitus according to the 2019 WHO criteria * Stage 3 or 4 periodontitis * No periodontal treatment in the previous 12 months * a minimum of 20 remaining teeth. Exclusion Criteria: * Smokers * Alcohol-dependent individuals * Pregnant or lactating women * Patients with renal disorders * Patients using medications that affect the periodontium
Where it's running
-
Bauru School of Dentistry
Bauru, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: Carla A. Damante, PhD
- Email: cdamante@usp.br
- Phone: +551432266064
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding tongue scraping to initial periodontal therapy to reduce bad breath
This will see if adding daily tongue scraping to standard initial periodontal treatment reduces bad breath in adults with generalized periodontitis.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.